Beijing Labtech Instruments Co., Ltd. (SHA:688056)
China · Delayed Price · Currency is CNY 32.95
+0.18 (0.55%)
May 28, 2026, 3:00 PM CST
SHA:688056 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 388.78 | 401.08 | 421.35 | 413.27 | 352.42 | 366.07 |
Other Revenue | - | - | 2.66 | 2.72 | 2.59 | 2.79 |
| 388.78 | 401.08 | 424.01 | 415.99 | 355 | 368.86 | |
Revenue Growth (YoY) | -6.90% | -5.41% | 1.93% | 17.18% | -3.76% | 5.81% |
Cost of Revenue | 210.82 | 219.38 | 233.07 | 233.99 | 186.33 | 190.5 |
Gross Profit | 177.97 | 181.7 | 190.94 | 182 | 168.67 | 178.36 |
Selling, General & Admin | 94.64 | 94.64 | 97.18 | 102.42 | 84.29 | 76.4 |
Research & Development | 50.39 | 48.54 | 51.27 | 52.22 | 38.4 | 31.38 |
Other Operating Expenses | -1.99 | -2.6 | 1.11 | 0.56 | 1.44 | 1.58 |
Operating Expenses | 143.04 | 140.58 | 151.17 | 156.18 | 125.37 | 110.01 |
Operating Income | 34.92 | 41.12 | 39.77 | 25.82 | 43.31 | 68.35 |
Interest Expense | - | - | -0.1 | -0.05 | -0.06 | - |
Interest & Investment Income | 3.58 | 4.33 | 9.11 | 7.82 | 7.96 | 9.37 |
Currency Exchange Gain (Loss) | - | - | -1.43 | -0.21 | -0.26 | -0.46 |
Other Non Operating Income (Expenses) | 3.38 | 4.36 | -0.8 | -0.89 | -0.72 | -0.39 |
EBT Excluding Unusual Items | 41.88 | 49.81 | 46.54 | 32.49 | 50.23 | 76.88 |
Impairment of Goodwill | - | - | -8.53 | -5.14 | - | - |
Gain (Loss) on Sale of Investments | 0.61 | 0.17 | 0.94 | -0.27 | 0.35 | - |
Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0 | -0 | -0 | 0.01 |
Asset Writedown | -3.64 | -3.84 | - | - | - | - |
Legal Settlements | - | - | - | - | - | 2 |
Other Unusual Items | - | - | 4.79 | 1.34 | 0.62 | 3.03 |
Pretax Income | 38.84 | 46.12 | 43.74 | 28.43 | 51.19 | 81.91 |
Income Tax Expense | 4.6 | 5.73 | 4.59 | 0.87 | 6.57 | 12.5 |
Earnings From Continuing Operations | 34.24 | 40.4 | 39.15 | 27.56 | 44.62 | 69.41 |
Net Income | 34.24 | 40.4 | 39.15 | 27.56 | 44.62 | 69.41 |
Net Income to Common | 34.24 | 40.4 | 39.15 | 27.56 | 44.62 | 69.41 |
Net Income Growth | -15.12% | 3.19% | 42.03% | -38.23% | -35.71% | 6.44% |
Shares Outstanding (Basic) | 67 | 67 | 66 | 67 | 67 | 67 |
Shares Outstanding (Diluted) | 67 | 67 | 66 | 67 | 67 | 67 |
Shares Change (YoY) | 1.41% | 1.47% | -1.30% | 0.93% | -0.21% | 19.75% |
EPS (Basic) | 0.51 | 0.60 | 0.59 | 0.41 | 0.67 | 1.04 |
EPS (Diluted) | 0.51 | 0.60 | 0.59 | 0.41 | 0.67 | 1.04 |
EPS Growth | -16.29% | 1.70% | 43.90% | -38.81% | -35.58% | -11.11% |
Free Cash Flow | 16.92 | 33.31 | 50.18 | 16.22 | -19.86 | -28.4 |
Free Cash Flow Per Share | 0.25 | 0.49 | 0.76 | 0.24 | -0.30 | -0.43 |
Dividend Per Share | - | - | 0.720 | 0.800 | 0.200 | 0.350 |
Dividend Growth | - | - | -10.00% | 300.00% | -42.86% | 16.67% |
Gross Margin | 45.77% | 45.30% | 45.03% | 43.75% | 47.51% | 48.35% |
Operating Margin | 8.98% | 10.25% | 9.38% | 6.21% | 12.20% | 18.53% |
Profit Margin | 8.81% | 10.07% | 9.23% | 6.63% | 12.57% | 18.82% |
Free Cash Flow Margin | 4.35% | 8.30% | 11.83% | 3.90% | -5.59% | -7.70% |
EBITDA | 49.84 | 56 | 54.49 | 38.98 | 51.14 | 74.14 |
EBITDA Margin | 12.82% | 13.96% | 12.85% | 9.37% | 14.41% | 20.10% |
D&A For EBITDA | 14.92 | 14.88 | 14.73 | 13.16 | 7.83 | 5.79 |
EBIT | 34.92 | 41.12 | 39.77 | 25.82 | 43.31 | 68.35 |
EBIT Margin | 8.98% | 10.25% | 9.38% | 6.21% | 12.20% | 18.53% |
Effective Tax Rate | 11.85% | 12.41% | 10.49% | 3.07% | 12.83% | 15.26% |
Revenue as Reported | - | - | 424.01 | 415.99 | 355 | 368.86 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.